[HTML][HTML] Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

H Pan, R Peto, AMH Restrepo, MP Preziosi… - The Lancet, 2022 - Elsevier
… -label, randomised trial in patients hospitalised with COVID-19. It was designed and conducted
by … In early 2020, no specific treatments had been developed for COVID-19, so Solidarity …

Cardiac complications in patients hospitalised with COVID-19

…, CAPACITY-COVID collaborative … - … Heart Journal: Acute …, 2020 - academic.oup.com
… In conclusion, this large study in 3011 hospitalised patients with confirmed COVID-19 shows
that the overall incidence of serious cardiac complications is low, despite a frequent history …

[HTML][HTML] Survival study of hospitalised patients with concurrent COVID19 and haematological malignancies

F Martín‐Moro, J Marquet, M Piris… - British journal of …, 2020 - ncbi.nlm.nih.gov
… One study reported 13 COVID19 cases in a cohort of 128 hospitalised patients with … of
hospitalised patients with concurrent haematological malignancies and COVID19, …

Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds

I Torjesen - BMJ: British Medical Journal (Online), 2020 - search.proquest.com
… other outcomes in hospitalised patients treated for covid-19, … hydroxychloroquine in patients
hospitalised with covid-19. We … The data show the death rate at 28 days in covid-19 patients

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation

A Beurnier, EM Jutant, M Jevnikar… - European …, 2020 - Eur Respiratory Soc
… of 75 non-asthmatic patients hospitalised for COVID-19 pneumonia in our hospital during the
same … patients were thus not overrepresented among COVID-19 inpatients. In addition, no …

Features of anosmia in COVID-19

T Klopfenstein, NJ Kadiane-Oussou, L Toko… - Medecine et maladies …, 2020 - Elsevier
… , 37% of our patients were hospitalised. To our … patients (≥ 18 years) with confirmed
COVID-19 who were examined at the infectious disease consultation or hospitalised in the hospital

Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms

AAR Mohamed-Hussein, MT Amin… - … of Tuberculosis and …, 2021 - ingentaconnect.com
… , hospitalised patients reported fewer long COVID-19 symptoms … examining risk factors for
long COVID hospitalisation, it was … it has been found that non-hospitalised COVID-19 patients

Respiratory follow-up of patients with COVID-19 pneumonia

PM George, SL Barratt, R Condliffe, SR Desai… - Thorax, 2020 - thorax.bmj.com
… In a Chinese study of 1099 hospitalised COVID-19 patients, 173 patients (16%) had severe
COVID-19 is considerable—in a large UK study, in-hospital mortality was 26% for patients on …

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

JL Pablos, M Galindo, L Carmona, A Lledó… - Annals of the …, 2020 - ard.bmj.com
… In this matched cohort study, we show that among hospital patients with chronic … risk factor
for poor COVID-19 outcomes. Comorbidities associated with severe COVID-19 in the general …

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Z Temesgen, CD Burger, J Baker, C Polk… - The Lancet …, 2022 - thelancet.com
… in hospitalised patients with COVID-19, with a safety profile similar to that of placebo. The
added value of lenzilumab beyond other immunomodulators used to treat COVID-19 alongside …